Generics Poised for Takeoff: A Report and Interview with Medco CEO

Over $100 billion in name brand drugs are coming off patent soon, according to the most recent tally, with 2010-2012 becoming the critical period for generics.  Growth in demand for generics has also boosted Medco's business, according to CEO David Snow.

Play Video

David Snow, CEO of Medco on Generic Drug Market Growth - Bloomberg

Bloomberg - (BLOOM)

Feb. 21, 2007. 01:48 PM EST